These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9783375)
1. [Intravenous immunoglobulins (IVIG) in treatment of an antiphospholipid syndrome in pregnancy]. Heilmann L; Berg C; von Tempelhoff GF; Gehler J; Zimmer B; Wolf H Z Geburtshilfe Neonatol; 1998; 202(4):164-7. PubMed ID: 9783375 [TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome. Arnout J; Spitz B; Wittevrongel C; Vanrusselt M; Van Assche A; Vermylen J Thromb Haemost; 1994 Jun; 71(6):741-7. PubMed ID: 7974342 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Kaaja R; Julkunen H; Ammälä P; Palosuo T; Kurki P Acta Obstet Gynecol Scand; 1993 Jan; 72(1):63-6. PubMed ID: 8382439 [TBL] [Abstract][Full Text] [Related]
4. Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome. Bortolati M; Marson P; Chiarelli S; Tison T; Facchinetti M; Gervasi MT; De Silvestro G; Ruffatti A Ther Apher Dial; 2009 Apr; 13(2):157-60. PubMed ID: 19379156 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies in women at risk for preeclampsia. Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G; Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189 [TBL] [Abstract][Full Text] [Related]
6. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study. Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917 [TBL] [Abstract][Full Text] [Related]
8. [The role of antiphospholipid antibodies in patients with pre-eclampsia]. Schneider DM; Heilmann L; von Tempelhoff GF; Berg C; Spanuth E Zentralbl Gynakol; 1999; 121(12):623-6. PubMed ID: 10666875 [No Abstract] [Full Text] [Related]
9. [Primary antiphospholipid antibody syndrome in pregnancy--successful pregnancy outcome after intravenous immunoglobulin administration]. Rosen AC; Anegg B Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):410-3. PubMed ID: 8974894 [TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome and pregnancy]. Romero Arauz JF; García Alonso López A; González AL; Rivera Velásquez P; Ayala Méndez JA Ginecol Obstet Mex; 2006 Jul; 74(7):367-75. PubMed ID: 16970127 [TBL] [Abstract][Full Text] [Related]
11. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions. Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690 [TBL] [Abstract][Full Text] [Related]
12. [Combined therapy in pregnancy with primary antiphospholipid syndrome]. Szodoray P; Bacskó G; Lakos G; Zeher M Orv Hetil; 2003 Dec; 144(49):2411-3. PubMed ID: 14725207 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibody syndrome and fetal outcome. Djelmis J; Radoncić E; Ivanisević M Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731 [TBL] [Abstract][Full Text] [Related]
14. A literature review on the antiphospholipid syndrome and the effect on childbearing. Vials JM Midwifery; 2001 Jun; 17(2):142-9. PubMed ID: 11399135 [TBL] [Abstract][Full Text] [Related]
15. High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report. Ogishima H; Ito S; Tsutsumi A; Sugihara M; Goto D; Matsumoto I; Obata-Yasuoka M; Hamada H; Yoshikawa H; Takahashi H; Murashima A; Sumida T Int J Rheum Dis; 2010 Aug; 13(3):e32-5. PubMed ID: 20704608 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. Piette JC; Lê Thi Huong D; Wechsler B Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S51-4. PubMed ID: 10896991 [TBL] [Abstract][Full Text] [Related]
17. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Le Thi Thuong D; Tieulié N; Costedoat N; Andreu MR; Wechsler B; Vauthier-Brouzes D; Aumaître O; Piette JC Ann Rheum Dis; 2005 Feb; 64(2):273-8. PubMed ID: 15647435 [TBL] [Abstract][Full Text] [Related]
18. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin. Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529 [TBL] [Abstract][Full Text] [Related]